Avadel Pharmaceuticals plc (AVDL)

United States Steel Revenue

Avadel Pharmaceuticals had revenue of $68.13M in the quarter ending June 30, 2025, with 64.15% growth. This brings the company's revenue in the last twelve months to $221.08M, up 132.35% year-over-year. In the year 2024, Avadel Pharmaceuticals had annual revenue of $169.12M with 504.79% growth.

• Revenue (ttm): $221.08M
• Revenue Growth: +132.35%
• P/S Ratio: 5.85
• Revenue / Employee: $1,175,931
• Employees: 188
• Market Cap: 1.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	169.12M	141.15M	504.79%
Dec 31, 2023	27.96M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	22.33M	-36.88M	-62.28%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.